Loading...

NHS Funding And Acquisitions Will Transform Healthcare Systems

Published
11 Feb 25
Updated
01 May 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-10.7%
7D
-5.4%

Author's Valuation

CA$15.5341.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 01 May 25

Fair value Increased 53%

Shared on 23 Apr 25

Fair value Decreased 28%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.2%.

Shared on 17 Apr 25

Fair value Decreased 3.71%

AnalystConsensusTarget has increased revenue growth from 13.6% to 17.7%.

Shared on 09 Apr 25

Fair value Increased 3.85%

Shared on 02 Apr 25

Fair value Decreased 5.16%

AnalystConsensusTarget has decreased revenue growth from 21.1% to 17.7%.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 21%

AnalystConsensusTarget has increased revenue growth from 14.7% to 21.1% and decreased shares outstanding growth rate from 0.1% to 0.1%.

Shared on 13 Mar 25

Fair value Decreased 11%

AnalystConsensusTarget has decreased revenue growth from 20.6% to 14.7%, increased future PE multiple from 36.9x to 42.9x and increased shares outstanding growth rate from 0.1% to 0.1%.